Genentech ends $2b cancer cell therapy pact with Adaptive
FierceBiotech - 18-Aug-2025Pharma giant retreats from costly cell therapy deals amid layoffs and R&D cuts
Join the club for FREE to access the whole archive and other member benefits.
Track where the serious money is being invested in the longevity industry.
Pharma giant retreats from costly cell therapy deals amid layoffs and R&D cuts
Gordon Sanghera to leave after 20 years as takeover interest grows in UK DNA sequencing firm
New funding will help expand OneSkin’s reach and target ageing at the cellular level
Biotech startup’s valuation soars as it advances de novo protein generation with AI models.
Click on resource name for more details.
Translating Aging podcast episode- Chris and Sergey discuss how investment strategies are driving the future of longevity biotech
22-Sep-2025
Conference gathering longevity experts and investors at one place (Gstaad, Switzerland)
30-Aug-2025
Opportunity to invest in longevity with investors, longevity entrepreneurs, scientists and policy makers (Aix-en-Provence, France)
18-Jul-2025
Webinar organised by The Kitalys Institute Targeting Healthy Longevity 2025 (FREE)
11-Jun-2025
Summit exploring the Aging Code through AI organised by Longevity Global (Cambridge, MA, USA)
Great to see a startup willing to explicitly state they are treating ageing itself as a disease
Adrian reviews a range of finalists trying to track cancer, blood oxygenation, retinal scans, and cardiac health
Skincare product R&D budgets exceed the National Institute on Aging's budget - let's get it focussed on real anti-aging science